1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: January 25 -31, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: January 25 -31, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Martin A. Makary, M.D., M.P.H., Commissioner for Food and Drugs

Event Date: 01/28/2026
Location: Washington, DC
Subject: 2026 Well Characterized Biotech Products (WCBP) Symposium - Integrating Science, Regulations, and Digitalization for Global Patient-Centered Care; Speaker: Fireside Chat
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Senior leaders from cancer centers, health systems, industry, and patient advocacy

Event Date: 01/28/2026
Location: Washington, DC
Subject: Research and Development Forum
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry

Event Date: 01/29/2026
Location: Silver Spring, MD
Subject: Regulatory Approaches to the Treatment of ALS
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Caitlin Bellina, James Worthington, Matthew Bellina (Patient Advocate);

Event Date: 01/29/2026
Location: Silver Spring, MD
Subject: Oral Anti-Amyloid Treatment for Alzheimer’s
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Muneer Satter representatives

Official Name: Sara Brenner, M.D., M.P.H., Principal Deputy Commissioner for Food and Drugs

No Significant Event

Official Name: Sean R. Keveney, Chief Counsel

No Significant Event

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Kyle Diamantas, J.D., Deputy Commissioner for Human Foods

Event Date: 01/26/2026
Location: Brussels, Belgium 
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: MEGAN VELEZ; FAZILA SHAKIR; DONALD PRATER; ALESSANDRO FIORELLI; KATHERINE SERRANO; 
Non FDA Participant/Group: Caroline Boeshertz, Claire Bury, Panayiotis Demetriou (Directorate, General Health and Food Safety, European Commission);

Event Date: 01/26/2026
Location: Brussels, Belgium
Subject: Nutrition and Food Safety Issues of Mutual Interest
FDA Participant/Group: MEGAN VELEZ; FAZILA SHAKIR; DONALD PRATER; ALESSANDRO FIORELLI; KATHERINE SERRANO;
Non FDA Participant/Group: FoodDrinkEurope representatives

Event Date: 01/27/2026
Location: Berlin, Germany
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: MEGAN VELEZ; FAZILA SHAKIR; DONALD PRATER; ALESSANDRO FIORELLI; KATHERINE SERRANO;
Non FDA Participant/Group: German Federal Institute for Risk Assessment representatives

Event Date: 01/27/2026
Location: Berlin, Germany 
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: MEGAN VELEZ; FAZILA SHAKIR; DONALD PRATER; ALESSANDRO FIORELLI; KATHERINE SERRANO;
Non FDA Participant/Group: German Federal Office of Consumer Protection and Food Safety representatives

Event Date: 01/29/2026
Location: Parma, Italy
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: MEGAN VELEZ; FAZILA SHAKIR; DONALD PRATER; ALESSANDRO FIORELLI; KATHERINE SERRANO;
Non FDA Participant/Group: European Food Safety Authority representatives

Official Name: Barclay Butler, Ph.D., Deputy Commissioner for Operations

No Significant Event

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives

Event Date: 01/28/2026
Location: Virtual
Subject: Manufacturing of Generic Drugs in Shortage
FDA Participant/Group: N/A
Non FDA Participant/Group: Edward John Allera (Buchanan Ingersoll & Rooney);

Event Date: 01/29/2026
Location: Virtual
Subject: Accelerating U.S. Biotech
FDA Participant/Group: SAMUEL DORAN; KARIM MIKHAIL; LUKE HALL; BENJAMIN COOK; 
Non FDA Participant/Group: Thomas Hotchkiss, Zach Weinberg (Curie.bio);

Event Date: 01/29/2026
Location: Silver Spring, MD
Subject: Cell and Gene Therapies (CGT) Matters
FDA Participant/Group: KARIM MIKHAIL; BRIAN FAHEY; 
Non FDA Participant/Group: Tim Hunt (Alliance for Regenerative Medicine); John Stone (BGR Government Affairs, LLC);

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations

No Significant Event

Official Name: Vinayak Prasad, M.D., M.P.H., Director, Center for Biologics and Research

No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Tracy Beth Høeg M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products

No Significant Event

Official Name: Timothy Schell, Ph.D., Director, Center for Veterinary Medicine

No Significant Event

Back to Top